Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Chief Counsel Says Generic Firms Make Strong Case For Preemption

This article was originally published in The Pink Sheet Daily

Executive Summary

Generic product liability suits are on the rise, which could result in more generic drug makers arguing for federal preemption, Bradshaw says.

You may also be interested in...



Final Rx Labeling Rule Should Not Preempt State Product Liability Laws, States Say

National Conference of State Legislatures alleges that FDA’s final labeling rule will include language limiting state product liability laws.

Final Rx Labeling Rule Should Not Preempt State Product Liability Laws, States Say

National Conference of State Legislatures alleges that FDA’s final labeling rule will include language limiting state product liability laws.

FDA Chief Counsel Is Assistant Attorney General Bradshaw

Bradshaw brings extensive high-level government service experience to the position as he permanently replaces former Chief Counsel Troy. Deputy Chief Counsel Masoudi has served in the position on an interim basis since Troy’s departure in November.

Topics

UsernamePublicRestriction

Register

MT142639

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel